LMDX - LumiraDx Teams Up with AstraZeneca & Everton in the Community to Open England's First Heart & Lung Screening Hub

2023-10-23 08:06:40 ET

DENVER, Colo., Oct 23, 2023 ( www.247marketnews.com )- LumiraDx Limited (NASDAQ: LMDX) announced, after Friday’s market close, that it formed a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub, which is scheduled for November opening.

The collaboration is the result of an unrestricted grant funding from AstraZeneca and run by Everton in the Community, the official charity of Everton Football Club. The Liverpool-based hub will provide significant support for individuals suffering from chronic breathlessness and other heart and lung-related conditions in a community-based setting.

LumiraDx is trading at $0.279, up $0.19 (+212.56%), on 27.29M premarket shares traded.

Its 52-week range is $ 0.0849 to 1.61. This move is …

The post LumiraDx Teams Up with AstraZeneca & Everton in the Community to Open England’s First Heart & Lung Screening Hub appeared first on 24/7 Market News .

For further details see: